Relation

Key Public Health Considerations for COVID-19 Related Policy

  • Current lack of understanding of the prevalence and efficacy of antibodies in individuals exposed to both milder and more acute COVID
  • If there is immunity from antibodies, the duration of immunity is unknown
  • Subsequent inability to determine how much current herd immunity is in a population or is required to safely reopen economies
  • Present medical and public policy nuances and challenges associated with safe and effective development and distribution of a vaccine to populations

0

2

Updated 2021-01-05

Tags

SARS-CoV-2 (COVID-19)

Biomedical Sciences